-
Tamoxifen in Research: Protocols, Advanced Use, and Troubles
2026-05-04
Tamoxifen, a selective estrogen receptor modulator, is pivotal for gene knockout, cancer, and antiviral research. This article translates the latest mechanistic evidence and protocol optimizations into actionable workflows, empowering scientists to maximize reproducibility and uncover new biological insights.
-
TaqI Restriction Endonuclease: Fast, Precise DNA Cleavage Gu
2026-05-03
TaqI Restriction Endonuclease (SKU K3053) enables rapid, sequence-specific digestion of plasmid, PCR, or genomic DNA, streamlining workflows where time and cloning efficiency are critical. It is appropriate for applications requiring fast, sticky-end DNA cleavage but should not be used in diagnostic or clinical settings, nor where blunt-end digestion is required.
-
CD40 and STING Competition Drives IRF4+ B Cell Activation in
2026-05-02
This study reveals how competitive binding between CD40 and STING with TRAF2 regulates IRF4-mediated B cell activation within tertiary lymphoid structures (TLS) in esophageal squamous cell carcinoma (ESCC). The findings uncover a mechanistic link between local immunity and tumor prognosis, offering new avenues for biomarker and therapeutic target development.
-
Synergistic PI3K–AKT–ERK Blockade Overcomes Gefitinib Resist
2026-05-01
Deng et al. developed a rational nanoplatform for co-delivery of gefitinib and crizotinib, achieving dual PI3K–AKT and ERK pathway suppression in lung adenocarcinoma models. This approach addresses both drug resistance and metastasis, offering a clinically translatable strategy for overcoming the limitations of current EGFR-TKI therapies.
-
IR-1061: Near Infrared Fluorescent Dye for In Vivo Imaging
2026-05-01
IR-1061 stands out as a near infrared fluorescent dye optimized for deep tissue and vascular imaging, offering robust signal clarity with minimal autofluorescence. This guide translates cutting-edge research into actionable workflows, troubleshooting, and comparative insights for biomedical imaging experiments.
-
Applied Protocols with Minocycline HCl in Inflammation Resea
2026-04-30
Minocycline HCl stands out as both a powerful antimicrobial and a versatile anti-inflammatory agent, uniquely suited for scalable inflammation and neuroprotection assays. This article delivers hands-on workflows, troubleshooting insights, and data-driven optimization tips for deploying minocycline hydrochloride in advanced cell and EV-based research.
-
Oxaliplatin in Cancer Biology: Resistance, Mechanisms, and A
2026-04-30
Explore the multifaceted role of Oxaliplatin, a platinum-based chemotherapeutic agent, in cancer biology research. This article uniquely dissects resistance mechanisms and offers actionable strategies for leveraging Oxaliplatin in DNA damage, apoptosis, and chemoresistance assays.
-
Stroma-Mediated Chemoresistance in PDAC: 3D Organoid-CAF Mod
2026-04-29
Schuth et al. introduce a patient-specific 3D co-culture system for pancreatic cancer, integrating tumor organoids with matched cancer-associated fibroblasts to model stroma-driven chemoresistance. This approach reveals critical tumor-stroma interactions underpinning drug resistance and provides a robust platform for personalized oncology studies.
-
SGI-1027 Induces Mitochondrial Apoptosis in HCC Cells
2026-04-29
This study establishes SGI-1027 as a potent DNA methyltransferase inhibitor that induces dose-dependent apoptosis in Huh7 hepatocellular carcinoma cells via the mitochondrial pathway. The findings advance understanding of epigenetic modulation as a strategy for tumor suppressor gene reactivation and targeted cancer therapy.
-
FASN Inhibition Primes Cancer Cells for Apoptosis via BCL-2
2026-04-28
This study reveals that fatty acid synthase (FASN) inhibition in cancer cells heightens mitochondrial apoptotic priming by upregulating pro-apoptotic BH3-only proteins. The findings demonstrate that FASN blockade sensitizes tumors to BCL-2 family inhibitors such as ABT-263 (Navitoclax), providing a mechanistic foundation for rational combination therapies in oncology.
-
Low-Dose Orlistat Enhances Oxaliplatin Efficacy in Colorecta
2026-04-28
This study demonstrates that low-dose orlistat synergistically enhances the antitumor effect of oxaliplatin in colorectal cancer models by increasing apoptosis through molecular crosstalk. The findings provide mechanistic insights and a rationale for combination strategies to overcome chemoresistance in metastatic colorectal cancer therapy.
-
Macrophage EVs Enclosed miR-660 Drives Breast Cancer Metasta
2026-04-27
This study uncovers a key tumor-promoting mechanism in breast cancer, demonstrating that microRNA-660, packaged within extracellular vesicles from tumor-associated macrophages, enhances metastatic progression via the KLHL21/IKKβ/NF-κB p65 axis. The findings highlight a potential therapeutic target and deepen our understanding of cell–cell communication in the tumor microenvironment.
-
Anti-Inflammatory, Anti-Angiogenic Airway Stent Suppresses T
2026-04-27
Zhao et al. engineered a dual-function airway stent combining anti-inflammatory and anti-angiogenic activities to address tracheal in-stent restenosis (TISR). Their approach demonstrated reduced fibrosis, angiogenesis, and microbial colonization in preclinical models, highlighting a promising translational advance for airway stenting complications.
-
Acetylcysteine in Advanced Tumor Microenvironment Modeling
2026-04-26
Explore how Acetylcysteine drives innovation in tumor microenvironment and chemoresistance research. This in-depth review highlights unique mechanistic insights and protocol strategies for leveraging N-acetyl-L-cysteine in complex 3D co-culture assays.
-
TaqI Restriction Endonuclease: Rapid, Specific DNA Digestion
2026-04-25
TaqI Restriction Endonuclease (SKU K3053) offers a rapid and reliable solution for specific DNA cleavage in plasmid, PCR product, or genomic DNA workflows. It is designed for research use only, supporting applications where expedited, sticky-end DNA digestion is essential and should not be used for diagnostic or medical purposes.